NeuShen Therapeutics Closes $20M Series Pre-A Financing for CNS Drug Development
NeuShen Therapeutics has announced the successful closure of a $20 million Series pre-A financing round...
Zelgen Files NDA for Jacktinib to Treat Myelofibrosis in China
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that it has filed a New...
Innovent Biologics Reports 15.3% Revenue Growth in 2022 Interim Results
China-based Innovent Biologics, Inc. (HKG: 1801) has released its 2022 interim report, recording RMB 2.24...
Lepu Biotechnology’s MRG003 Receives Breakthrough Therapy Designation for Nasopharyngeal Carcinoma
China-based Lepu Biotechnology Co., Ltd (HKG: 2157) has announced that it has received Breakthrough Therapy...
Lepu Biotechnology’s PD-1 Inhibitor HX008 Gains New Indication Approval
China-based Lepu Biotechnology Co., Ltd (HKG: 2157) has announced that it has received another indication...
Neurophth Biotechnology Doses First Patient in Phase III Trial for NR082
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced that the first patient has been...
Bio-Thera Solutions Completes Phase I Study for COVID-19 Antibody BAT2022
Guangzhou-based Bio-Thera Solutions (SHA: 688177) has announced the completion of all dosage groups (from 100...
Allergan Aesthetics Opens Shanghai Innovation Center for Medical Aesthetics
Allergan Aesthetics, a division of AbbVie, has officially opened its Shanghai innovation center, marking a...
Biosyngen to Establish Cell Therapy GMP Facility in Singapore
Biosyngen has announced plans to establish a Cell Therapy GMP Facility in Singapore, aimed at...
Luye Pharma Reports Decline in H1 Revenue and Profits Amid Market Challenges
China-based Luye Pharma Group (HKG: 2186) has released its 2022 interim report, recording RMB 2.85...
Parexel Opens Clinical Study Supply Chain Center in Suzhou
US-based contract research organization (CRO) Parexel has announced the opening of its clinical study supply...
Abbisko Therapeutics Doses First Patient in Phase I Study of ABSK043
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced that the first patient has...
Arctic Vision Enrolls First Patient in Phase III Study for ARVN002
China-based ophthalmology specialist Arctic Vision has announced the enrollment of the first patient in a...
3D Medicines Partners with Denfo Medical for Cancer Therapy Development
China-based 3D Medicines has entered into a strategic partnership with compatriot firm Denfo Medical Group,...
Simcere Grants Almirall Global Rights to Autoimmune Drug SIM0278
China’s Jiangsu Simcere Pharmaceutical Co., Ltd (HKG: 2096) has entered into a licensing agreement with...
Insight Lifetech Raises Funds for Cardiovascular Solutions Expansion
Insight Lifetech Co., Ltd, a Shenzhen-based provider of cardiovascular precision intervention solutions, has reportedly secured...
Santen Pharmaceutical Launches New Plant Construction in Suzhou
Japan-based Santen Pharmaceutical Co. has launched the construction of a new plant in Suzhou, Jiangsu...
Legend Biotech’s Carvykti Approved in Japan for Relapsed Multiple Myeloma
China-based Legend Biotech Corporation (NASDAQ: LEGN) has announced that Japan’s Ministry of Health, Labour and...
Eureka Biotech Partners with Ucello for Universal CAR-T Cell Therapy Development
Shenzhen Eureka Biotechnology Co., Limited, a China-based biotech firm, has entered into a partnership with...
Merck Sharp & Dohme Partners with Sinopharm for Molnupiravir in China
US-based Merck Sharp & Dohme (MSD, NYSE: MRK) has entered into a cooperation framework agreement...